期刊
ARCHIVES OF PHARMACAL RESEARCH
卷 38, 期 3, 页码 414-422出版社
PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-015-0570-2
关键词
Cancer stem cells; Tumor initiating cells; Chemo-resistance; Radio-resistance; Recurrence
资金
- National Research Foundation of Korea - Korea government (MSIP) [2011-0030074, 2011-0023431, 2012-M3A9B6055466]
- National Research Foundation of Korea [2011-0023431, 2011-0030074] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Several decades after the first notion that cancer cells are heterogeneous, not only histologically but also at the level of tumorigenicity, the existence of a tumor initiation population (so-called cancer stem cells) is now widely accepted. Here, we review the historical background leading up to the identification of this special cancer cell population and its role in the resistance of tumors to conventional therapies. In addition, we briefly review the clinical targeting strategy of the specific signaling network for cancer stem cells. Current clinical trials with newly developed drugs or older drugs for other uses are summarized to provide an understanding of the current status of strategies to target cancer stem cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据